Nautilus Biotechnology, Inc. (NAUT)
NASDAQ·Healthcare·Biotechnology
$2.23
-2.54%
Mkt Cap $303.72M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
Implied Upside
+12.3%
Consensus $2.50 vs current $2.23
NASDAQ·Healthcare·Biotechnology
$2.23
-2.54%
Mkt Cap $303.72M
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
+12.3%
Consensus $2.50 vs current $2.23